Evidence map›Paper›PMID 18768841›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells.

Zhao Zhao, Shuo Yu, Denise C Fitzgerald, Mohamed Elbehi, Bogoljub Ciric, A M Rostami, Guang-Xian Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Thymus-Derived CD4Journal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhao ZhaoDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Shuo Yu
Denise C Fitzgerald
Mohamed Elbehi
Bogoljub Ciric
A M Rostami
Guang-Xian Zhang
Thomas Jefferson University · US

Funding

TOLERENCE INDUCED BY I.V. MBP IN EAER01NS040085 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI ROSTAMI, A.M. · 2000 to 2009
$2.5M
NINDS NIH HHS R01 NS040085
6 · The paper itself

Abstract

We have previously shown that mice lacking the IL-12-specific receptor subunit beta2 (IL-12Rbeta2) develop more severe experimental autoimmune encephalomyelitis than wild-type (WT) mice. The mechanism underlying this phenomenon is not known; nor is it known whether deficiency of IL-12Rbeta2 impacts other autoimmune disorders similarly. In the present study we demonstrate that IL-12Rbeta2(-/-) mice develop earlier onset and more severe disease in the streptozotocin-induced model of diabetes, indicating predisposition of IL-12Rbeta2-deficient mice to autoimmune diseases. T cells from IL-12Rbeta2(-/-) mice exhibited significantly higher proliferative responses upon TCR stimulation. The numbers of naturally occurring CD25(+)CD4(+) regulatory T cells (Tregs) in the thymus and spleen of IL-12Rbeta2(-/-) mice were comparable to those of WT mice. However, IL-12Rbeta2(-/-) mice exhibited a significantly reduced capacity to develop Tregs upon stimulation with TGF-beta, as shown by significantly lower numbers of CD25(+)CD4(+) T cells that expressed Foxp3. Functionally, CD25(+)CD4(+) Tregs derived from IL-12Rbeta2(-/-) mice were less efficient than those from WT mice in suppressing effector T cells. The role of IL-12Rbeta2 in the induction of Tregs was confirmed using small interfering RNA. These findings suggest that signaling via IL-12Rbeta2 regulates both the number and functional maturity of Treg cells, which indicates a novel mechanism underlying the regulation of autoimmune diseases by the IL-12 pathway.

Indexed as

AnimalsCell DifferentiationCells, CulturedDiabetes Mellitus, ExperimentalFemaleGenetic Predisposition to DiseaseHyperglycemiaInterleukin-12MiceMice, Inbred C57BLMice, KnockoutReceptors, Interleukin-12Signal TransductionT-Lymphocytes, RegulatoryIl12rb2 protein, mouseInterleukin-12Receptors, Interleukin-12

Identifiers

PMID18768841
PMCPMC2679170
OpenAlexW1804122417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.